Reported Aug 6, 2014 · Terminated

Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi…

Daiichi Sankyo Pharma Development

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Daiichi Sankyo Pharma Development · 399 Thornall St · Edison, NJ · 08837-2236

Is this the product you have?

  • Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only
  • Manufactured forDaiichi Sankyo, Inc. Parsippany, NJ 07054 NDC 65597-113-30
Lot codes and dates
  • Lot #213655B Exp - 12/31/2017
Amount recalled
5 bottles

This recall covers 8 products

The agency filed one notice per product. You are reading one of them; the other 7 are below.

Where it was sold

  • Nationwide

Why it was recalled

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Daiichi Sankyo Pharma Development recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 16, 2015 · Data as of Sep 19, 5:02 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.